A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death - Wikidata - wikimedia - TriplyDB

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

http://www.wikidata.org/entity/Q28740749

about

Aptamers in Therapeutics Aptamers: A promising chemical antibody for cancer therapy Generation of Aptamers with an Expanded Chemical Repertoire Aptamer-Drug Conjugates Targeting Insulin Receptor with a Novel Internalizing Aptamer Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers.Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers Detection and characterization of cancer cells and pathogenic bacteria using aptamer-based nano-conjugates Peptide-fluorescent bacteria complex as luminescent reagents for cancer diagnosis.Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth.Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.DNA aptamers that target human glioblastoma multiforme cells overexpressing epidermal growth factor receptor variant III in vitro.Selective Targeting to Glioma with Nucleic Acid Aptamers Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.Identification of sequence-structure RNA binding motifs for SELEX-derived aptamers.Current progress of RNA aptamer-based therapeutics.Targeting Axl with an high-affinity inhibitory aptamer.Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.Smooth Muscle Cell-targeted RNA Aptamer Inhibits Neointimal Formation.Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL.Stable RNA nanoparticles as potential new generation drugs for cancer therapy.Inhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ aptamer.Aptamers and their potential to selectively target aspects of EGF, Wnt/β-catenin and TGFβ-smad family signaling.Application of aptamers for targeted therapeutics.Oncogenic protein interfaces: small molecules, big challenges.Oligonucleotide aptamers: new tools for targeted cancer therapy.Nucleic acid aptamers in cancer research, diagnosis and therapy.Trends in the Design and Development of Specific Aptamers Against Peptides and Proteins.The promotion of salinomycin delivery to hepatocellular carcinoma cells through EGFR and CD133 aptamers conjugation by PLGA nanoparticles.Advancement of the Emerging Field of RNA Nanotechnology.Controllable Self-Assembly of RNA Tetrahedrons with Precise Shape and Size for Cancer Targeting.Nucleic acids in human glioma treatment: innovative approaches and recent results Enhanced EGFR Targeting Activity of Plasmonic Nanostructures with Engineered GE11 Peptide.Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications.Molecular Elucidation of Disease Biomarkers at the Interface of Chemistry and Biology.Epidermal growth factor receptor aptamer-conjugated polymer-lipid hybrid nanoparticles enhance salinomycin delivery to osteosarcoma and cancer stem cells.Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression.

P2860

Q26738413-79404278-924A-4CAD-B4F3-B93A3A61EC61 Q26766832-15CDF242-785B-4054-93A5-495C7F8704A0 Q26782794-1A3A4F24-355E-4D3A-83C7-ED8268E9B0BA Q28468281-6C856643-F7FE-442A-A3AE-6B952E2AD900 Q28822291-2C9A4ACB-68FF-49BD-840C-912AEC60389F Q33582972-EE84EFE2-5133-4D83-9555-A8D24126B86D Q33705431-E1A79B7F-9385-4408-AB83-565C1C2528F7 Q33724277-BE7CD49F-AE2E-4A3A-82FA-23046702034F Q33832781-DD0C0517-7691-4824-AA95-4E69FE83800E Q34554135-4EE14A44-E581-46DE-98ED-8659860EAE0C Q34563134-5F0D0D4E-CA33-40DA-B14C-716EB178DD40 Q34695253-12D933C2-520E-4032-A50A-5C84078BF1C9 Q34914039-00A98E8D-5DF7-49AC-9942-FDEFFA824832 Q35059032-9C323275-0E3A-485F-A15E-15BE10384737 Q35740074-2A35F985-A533-41FF-B8CF-5FFCF0B6A31C Q35804765-744D023D-EE21-43D7-8BD0-8BE907409ABC Q36022113-B9F25F51-B2B5-42AF-9700-42AB2C5071D4 Q36365202-F9EFAF06-174A-4B02-8898-F8A90289D88A Q36460465-4E91B14B-88D6-4C47-9099-9649C941375A Q36490744-1EE050B4-7F77-4166-99BB-C3D51D8D2D7D Q36951272-7A4B6187-EF6F-4347-9C7F-55F21CE7FB56 Q37238771-4F333A6B-267A-475A-B5CA-2F786359BE6B Q37640468-217B7156-8A92-4B2D-A7E2-628611074C0E Q37696048-F004FA11-8B53-419B-B678-445CE48E9C72 Q38093337-AD277D56-ABB2-4236-9974-589FC5B12BD2 Q38096870-3102E82F-225C-42EA-822C-A599078CBEBC Q38195457-91C6BB0A-3D5B-45D0-9108-0350408BF418 Q38237132-7DF2A660-1061-4C56-8AB0-0E3EF94ED7BC Q38308357-F94F3319-2AD5-48D7-921D-4153F1764DDD Q38777639-9914CF81-98FB-4BAC-AF7A-D4F419A76922 Q38857110-5A81A704-57C1-400C-A583-A49122D6C513 Q39065708-D5557AC1-6A77-4450-8F98-AA1892BEAE01 Q41432210-64DF8F8F-87E7-40B9-95A1-56F0F5717804 Q42111511-E7B9AE4D-A016-438E-B081-2404D315BE25 Q47872054-71A51AAB-C8DB-4E75-A229-79EA7CD6BD02 Q47942947-51977164-DE35-4DCA-8043-CB976775CCFB Q48313209-18EED249-33B4-4966-929D-896560D1A089 Q49335412-70E6D145-6FB2-40C5-AB24-38FDD4F78D37 Q49529515-52EB4E98-6B73-40F1-A530-4FFE10D475C2 Q49918947-0615466E-8B20-4EE4-AAC5-36526BD1BF06

P2860

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

http://www.wikidata.org/entity/Q28740749

description

2011 nî lūn-bûn

@nan

2011 թուականին հրատարակուած գիտական յօդուած

@hyw

2011 թվականին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

@ast

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

@en

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

@nl

type

label

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

@ast

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

@en

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

@nl

prefLabel

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

@ast

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

@en

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

@nl

P1433

Q28740749-94FE0D16-2441-4982-AB42-FD5B2A856F19

P1476

Q28740749-67521D7B-167E-41EB-A4DE-7FF76DCC5B13

P2093

Q28740749-5591B2AA-C44F-421A-A042-3F2A020E9F00

Q28740749-599F6555-0AB2-40E0-BEB3-4D817F48A53D

Q28740749-8DB82F18-B069-493C-BC93-1B2BA0590657

Q28740749-F1CF2299-9A6B-4B86-AD0A-5C59A27EC1AF

P2860

Q28740749-0A4DFAC6-9F41-433A-A7D6-EC618C3C26C1

Q28740749-0D2FD322-9F52-485F-81DE-4F95D7D6745E

Q28740749-0EAF8879-DDF1-4D22-8B8E-F1D24DACC168

Q28740749-103B1A40-4CC9-4C62-9225-926E5FCE2E4B

Q28740749-134AC1B6-5900-452B-B179-A0B23106D730

Q28740749-13668610-2FC4-4553-8CF3-0D68260DA7FD

Q28740749-159953BD-671B-4EC4-A693-3FF5A5D8C1E5

Q28740749-18F2ABCC-475B-4FCD-97B9-BA982EF8B670

Q28740749-3B5ACE15-FCD9-4F13-90D5-B45ADDAC337B

Q28740749-4045424D-79EC-4947-8F10-A524A5A36E04

P304

Q28740749-477B4B1B-0DE2-4F5C-8B37-39CDCD73A338

P31

Q28740749-722FFB0C-2AB2-4134-9F2E-E692FAACAE9C

P3181

Q28740749-B96F4BE7-1C7D-45B4-B13D-F2771BDA0752

P356

Q28740749-49FE1239-0678-4A6C-B7CF-B3018F8E652D

P407

Q28740749-C1637251-FEA5-4DE6-A439-BC7AC6F2B5F1

P433

Q28740749-B1E008B0-9DAD-4B74-BCBE-316513565F1C

P478

Q28740749-C0FFC7F8-BFA0-47A5-A198-CA85EC9679ED

P50

Q28740749-17992A64-9376-4CCE-8BD3-EDD28361268E

Q28740749-774C4886-7FDB-4E47-8DB1-67F9AFABCC32

Q28740749-8C200EB3-A7B9-4C58-BFCF-C5C618393D3A

Q28740749-A24D6F78-8E2D-4AE0-8F2B-E284117701D6

P577

Q28740749-DE98B318-2EDB-4D5D-9BC7-7FECB285B591

P5875

Q28740749-8382FAC9-A45B-44A3-82D3-EB28309225D9

P698

Q28740749-CD8ED776-0143-4AB8-9319-8FF577333F24

P921

Q28740749-D748FBCD-27E0-416B-A108-B3220ADB4995

P932

Q28740749-DFE6FD24-6EB1-41C3-A887-10E4316FF311

P3181

P356

JOURNAL.PONE.0024071

P1433

P1476

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

@en

P2093

Andrea Affuso

http://www.w3.org/2001/XMLSchema#string

Immacolata Longobardo

http://www.w3.org/2001/XMLSchema#string

Laura Cerchia

http://www.w3.org/2001/XMLSchema#string

Vittorio de Franciscis

http://www.w3.org/2001/XMLSchema#string

P2860

From combinatorial peptide selection to drug prototype (II): targeting the epidermal growth factor receptor pathway

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

Untangling the ErbB signalling network

ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases

A cross-talk between TrkB and Ret tyrosine kinases receptors mediates neuroblastoma cells differentiation

Ligand-induced, receptor-mediated dimerization and activation of EGF receptor

Inhibition of cell proliferation by an anti-EGFR aptamer

Differential SELEX in human glioma cell lines

The ErbB signaling network: receptor heterodimerization in development and cancer

ERBB receptors and cancer: the complexity of targeted inhibitors

P304

e24071

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3451477

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0024071

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Gerolama Condorelli

Carla Lucia Esposito

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51641513

http://www.w3.org/2001/XMLSchema#string

P698

21915281

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

3167817

http://www.w3.org/2001/XMLSchema#string